LATEST

Urologists, lawmakers share experience, expertise at AACU event
Top 5 Dr. Rosevear blogs of 2017Dr. Henry Rosevear's most-read blog posts from 2017 cover topics including the AUA annual meeting, physician employment, and pain control.
Top 9 peer-reviewed prostate cancer papers of 2017Multiparametric MRI, USPSTF’s updated PSA screening recommendation, and the landmark STAMPEDE and LATITUDE trials were among this year’s highlights in the peer-reviewed literature for prostate cancer, according to Leonard G. Gomella, MD; Stacy Loeb, MD, MS; and J. Brantley Thrasher, MD.
Do you ‘feel the Bern’? What a single-payer system portends"While I don’t know if I 'feel the Bern' about a single-payer system, I also don’t think I would have to start looking for a second job if we transitioned to that system," writes Henry Rosevear, MD.
Survey: Urologists weigh in on MIPS, APMs, burnoutOnly one-fourth of urologists report understanding the choices available to them regarding the Merit-based Incentive Payment System and Advanced Alternative Payment Models created under Medicare’s Quality Payment Program, according to the Urology Times 2017 State of the Specialty survey.
Top 12 practice management articles of 2017Our most-read practice management articles covered topics including reimbursement, personal finance, and EHR fraud.
In-office andrology: Videos show office-based hydrocelectomy, vasectomy reversalThese videos depict key steps of office-based approaches to hydrocelectomy and vasectomy reversal.
Top 5 malpractice articles of 2017Ranging from advice on telephone triage to reports on cases involving circumcision requiring revision surgery to a missed kidney cancer diagnosis, these were our most-read “Malpractice Consult” columns online from 2017.
Biennial vs. annual prostate biopsies: What the data showAmong men undergoing active surveillance for low-risk prostate cancer, biennial biopsies appear to be an acceptable alternative to annual biopsies.
Prostate Ca test linked to reduction in biopsiesPatients with non-suspicious digital rectal exam findings and total PSA in the 4.0- to 10.0-ng/mL range are far less likely to be biopsied if they’ve undergone Prostate Health Index (phi) testing than if they don’t.

Poll